Please assess the completion status of the following clinical trial:

Trial Title: TAilored Post-Surgical Therapy in Early Stage NSCLC

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* NSCLC that is defined as other than predominantly squamous cell histology (squamous cell and/or mixed small cell, non-small cell histology is not permitted)~* Surgically resected NSCLC with pathological stage II or stage IIIA non-N2 (TNM classification 2008)~* Performance status (PS) = 0 or 1~* 18 years \<= age \< 70 years~* Signed inform consent~Exclusion Criteria:~* Squamous cell carcinoma~* Previous cancer excepted those treated for more than 5 years and considered cured, basocellular skin carcinoma, carcinoma in situ of uterine cervix~* Inadequate renal or cardiac functions~* Pregnant women~* Any of the following within 6 months prior to study enrollment: myocardial infarction, severe/unstable angina pectoris, coronary/peripheral artery bypass graft, NYHA class III or IV congestive heart failure, cerebrovascular accident or transient ischemic attack, grade ≥ 2 peripheral neuropathy, peptic ulcer disease, erosive esophagitis or gastritis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Standard chemotherapy
- B (Type: EXPERIMENTAL): Customized treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).